Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder

Biological Psychiatry

Volumn 47, Issue 3, 2000, Pages 174-182

  Fitzgerald, Kate Dimond ^a   Moore, Gregory J ^a   Paulson, Lori Anne ^a   Stewart, Carol M ^a   Rosenberg, David R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Magnetic resonance spectroscopy; N acetyl aspartate; Obsessive compulsive disorder; Pediatric; Thalamus

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; COMPULSIVE PERSONALITY DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; THALAMUS;

ADOLESCENT; ASPARTIC ACID; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHILD; CHOLINE; CORPUS STRIATUM; CREATINE; DOMINANCE, CEREBRAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE NET; NEURAL PATHWAYS; OBSESSIVE-COMPULSIVE DISORDER; PHOSPHOCREATINE; REFERENCE VALUES; THALAMUS;

EID: 0033984804     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00286-3     Document Type: Article

References (66)

1. Alexander GE, Crutcher MD, DeLong MR (1990): Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. In: Uylings HBM, VanEden CG, DeBruin JPC, Corner MA, Feenstra MGP, editors. Progress in Brain Research. Amsterdam: Elsevier Science, 119-146.
2. Ames D., Cummings J.L., Wirshing W.C., Quinn B., Mahler M. Repetitive and compulsive behavior in frontal lobe degenerations. J Neuropsychiatry Clin Neurosci. 6:1994;100-113.
3. Ammons R.B., Ammons C.H. Ammons Quick IQ Test. 1962;Psychological Test Specialist, New York.
4. Andreason N.C., Arndt S., Swayze V., Cizadlo T., Flaum M., O'Leary D., et al. Thalamic abnormalities in schizophrenics visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
5. Andreason N.C., Endicott J., Spitzer R.L., Winokur G. The family history method using diagnostic criteria Reliability and validity . Arch Gen Psychiatry. 34:1977;1229-1335.
6. Barker P.B., Breiter S.N., Soher B.J., Chatham J.C., Forder J.R., Samphilipo M.A., et al. Quantitative proton spectroscopy of canine brain In vivo and in vitro correlations . Magn Reson Med. 32:1994;157-163.
7. 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry. 155:1998;1584-1591.
8. Baxter L.R. Jr, Saxena S., Brody A.L., Ackermann R.F., Colgan M., Schwartz J.M., et al. Brain mediation of obsessive-compulsive disorder symptoms Evidence from functional brain imaging studies in the human and nonhuman primate . Semin Clin Neuropsychiatry. 1:1996;32-47.
9. Baxter L.R. Jr, Schwartz J.M., Bergman K.S. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;681-689.
10. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch Gen Psychiatry. 47:1990;840-848.
11. Bergmann F., Chaimovitz M., Pasternak V., Ramu A. Compulsive gnawing in rats after implantation of drugs into the ventral thalamus. A contribution to the mechanism of morphine action. Br J Pharmacol. 51:1974;197-205.
12. Berthier M.L., Kulisevsky J., Gironell A., Heras J.A. Obsessive-compulsive disorder associated with brain lesions Clinical phenomenology, cognitive function, and anatomic correlates . Neurology. 47:1996;353-361.
13. Birken D.L., Oldendorf W.H. N-Acetyl-L-aspartic acid A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain . Neurosci Biobehav Rev. 13:1989;23-31.
14. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry. 53:1996;595-606.
15. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 153:1996;191-199.
16. Cendes F., Andermann F., Preul M.C., Arnold D.L. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol. 35:1994;211-216.
17. Chakos M.H., Lieberman J.A., Bilder R.M., Borenstein M., Lerner G., Bogerts B., et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry. 151:1994;1430-1436.
18. Chiocca E.A., Martuza R.L. Neurosurgical therapy of obsessive compulsive disorder. Jenike M.A., Baer L., Minichiello W.E. Obsessive-Compulsive Disorder. Diagnosis and Treatment. 1990;283-294 Year Book Medical Publishing, Chicago. 2nd ed.
19. Cottraux J., Gerard D., Cinotti L., Froment J.C., Deiber M.P., Le Bars D., et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res. 6:1996;111-118.
20. Daniels D.L., Haughton V.M., Naidich T.P. Cranial and Spinal MRI An Atlas and Guide . 1987;Raven, New York.
21. Duyn J.H., Moonen C.T. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med. 30:1993;409-414.
22. Ebert D., Speck O., Konig A., Berger M., Hennig J., Hohagen F. 1-H-Magnetic resonance spectroscopy in obsessive-compulsive disorder Evidence for neuronal loss in the cingulate gyrus and the right striatum . Psychiatry Res. 74:1997;173-176.
23. Ebisu T., Rooney W.D., Graham S.H., Weiner M.W., Maudsley A.A. N-Acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus 1H magnetic resonance spectroscopic imaging . J Cereb Blood Flow Metab. 14:1994;373-382.
24. Fitzgerald K.D., MacMaster F.P., Paulson L.D., Rosenberg D.R. Neurobiology of childhood obsessive compulsive disorder. Child Adolesc Psychiatr Clin N Am. 8:1999;533-575.
25. Flament M.F., Whitaker A., Rapoport J.L. Obsessive compulsive disorder in adolescence An epidemiological study . J Am Acad Child Adolesc Psychiatry. 27:1988;764-771.
26. Gilbert AR, MacMaster FP, Moore GJ, Paulson LD, Keshavan MS, MacDonald AD, et al (in press): Thalamic volume and treatment response in pediatric obsessive compulsive disorder. Arch Gen Psychiatry.
27. Gill S.S., Lee Y.C., Ghatei M.A., Ghiglione M., Uttenthal L.O., Bloom S.R. The use of a rat isolated ileal preparation to investigate the release of neurotensin. Clin Exp Pharmacol Physiol. 11:1984;457-465.
28. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale, I Development, use and reliability . Arch Gen Psychiatry. 46:1989;1006-1011.
29. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
31. Hanna G.L. Demographic and clinical features of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 34:1995;19-27.
32. Hetherington H.P., Mason G.F., Pan J.W., Ponder S.L., Vaughan J.T., Twieg D.B., Pohost G.M. Evaluation of cerebral gray and white matter metabolic differences by spectroscopic imaging at 4.1 T. Magn Reson Med. 32:1994;565-571.
33. Hollingshead AB (1978): Four factor index of social status. Unpublished manuscript, Yale University, Department of Sociology, New Haven, CT.
34. Hugg J.W., Maudsley A.A., Weiner M.W., Matson G.B. Comparison of k-space sampling schemes for multidimensional MR spectroscopic imaging. Magn Reson Med. 36:1996;469-473.
35. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL) Initial reliability and validity data . J Am Acad Child Adolesc Psychiatry. 36:1997;980-988.
36. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet. 344:1994;1434.
37. Knights R, Norwood J (1980): Revised smoothed normative data on the Neuropsychological Test Battery for Children. Unpublished manuscript, Carleton University, Ottawa, Ontario, Canada.
38. Laplane D., Levasseur M., Pillon B., Dubois B., Baulac M., Mazoyer B., et al. Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain. 112:(pt 3):1989;699-725.
39. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale Initial testing of a clinician-rated scale of tic severity . J Am Acad Child Adolesc Psychiatry. 28:1989;566-573.
40. Lucey J.V., Costa D.C., Blanes T., Busatto G.F., Pilowsky L.S., Takei N., et al. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. Br J Psychiatry. 167:1995;629-634.
41. MacKay S., Meyerhoff D.J., Constans J.M. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol. 53:1996;167-174.
42. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy An in vivo method of estimating hippocampal neuronal depletion in schizophrenia . Psychol Med. 25:1995;1201-1209.
43. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S.J., Dolan R.J. Functional anatomy of obsessive compulsive phenomena. Br J Psychiatry. 164:1994;459-468.
44. Michaelis T., Merboldt K.D., Bruhn H., Hanicke W., Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo Quantification of localized proton MR spectra . Radiology. 187:1993;219-227.
45. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1:1989;27-36.
46. Moore G.J. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol. 28:1998;805-814.
47. Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res. 7:1992;95-100.
48. Pauls D.L., Alsobrook J.P. II, Goodman W., Rasmussen S., Leckman J.F. A family study of obsessive-compulsive disorder. Am J Psychiatry. 152:1995;76-84.
49. Perani D., Colombo C., Bressi S., Bonfanti A., Grassi F., Scarone S., et al. [18F] FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry. 166:1995;244-250.
50. Portas C.M., Goldstein J.M., Sheton M.E., Hokama H.H., Wible C.G., Fischer I., et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry. 43:1998;649-659.
51. Portenoy R.K., Jarden J.O., Sidtis J.J., Lipton R.B., Foley K.M., Rottenberg D.A. Compulsive thalamic self-stimulation A case with metabolic, electrophysiologic and behavioral correlates . Pain. 27:1986;277-290.
52. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 51:1994;62-70.
53. Rosenberg D.R., Keshavan M.S. Toward a neurodevelopmental model of obsessive compulsive disorder. Biol Psychiatry. 43:1998;623-640.
54. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., Dick E.L., Bagwell W.W., Seymour A.B., et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 54:1997;824-830.
55. Salt T.E., Eaton S.A. Functions of iontropic and metatropic glutamate receptors in sensory transmission in the mammalian thalamus. Prog Neurobiol. 48:1996;55-72.
56. Sasaki K., Miyakawa M., Sudo T., Yoshizaki F. Evaluation of marble burying behavior Induced alteration of monoamine metabolism in mouse brain . Nippon Yakurigaku Zasshi. 110:1997;205-213.
57. Scarone S., Colombo C., Livian S., Abbruzzese M., Ronchi P., Locatelli M., et al. Increased right caudate nucleus size in obsessive-compulsive disorder Detection with magnetic resonance imaging . Psychiatry Res. 45:1992;115-121.
58. Soher B.J., van Zijl P.C., Duyn J.H., Barker P.B. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med. 35:1996;356-363.
59. Staal W.G., Hulshoffpol H.E., Schnack H., van der Schot A.C., Kahn R.S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry. 155:1998;1784-1786.
60. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, New York.
61. Tsai G., Coyle J.T. N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 46:1995;531-540.
62. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem. 59:1992;55-61.
63. Valleni-Basile L.A., Garrison C.Z., Jackson K.L., Waller J.L., McKeown R.E., Addy C.L., et al. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry. 33:1994;782-791.
64. Vion-Dury J., Nicoli F., Salvan A.M., Confort-Gouny S., Dhiver C., Cozzone P.J. Reversal of brain metabolic alterations with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet. 345:1995;60-61.
65. Weschler D. Weschler Intelligence Scale for Children. 1991;Psychological Corp, New York.
66. Wolff R.P., Wolff L.S. Assessment and treatment of obsessive compulsive disorder in children. Behav Modif. 15:1991;372-393.